Document is current
Any future updates will be listed below
-
Authors
,
Bauer, Emanuel C. A.
Schochter, Fabienne
Widschwendter, Peter
DeGregorio, Amelie
Andergassen, Ulrich
Friedl, Thomas W. P.
Fasching, Peter A.
Fehm, Tanja
Schneeweiss, Andreas
Beckmann, Matthias W.
Pantel, Klaus
Janni, Wolfgang
Rack, Brigitte
Scholz, Christoph
- License Information
-
More Information
Article History
Received: 12 March 2018
Accepted: 14 June 2018
First Online: 21 June 2018
Compliance with Ethical Standards
:
: B. Rack, A. Schneeweiss, T. Fehm, M. W. Beckmann, and W. Janni have received research funding from AstraZeneca, Chugai, Lilly, Novartis, and Sanofi-Aventis. B. Rack, T. Fehm, K. Pantel, and W. Janni received research funding and speaker honoraria from Veridex. M. W. Beckmann acted as advisors for Novartis and Sanofi-Aventis. A. Schneeweiss received speaker honoraria from AstraZeneca, Chugai, Lilly, Novartis, and Sanofi-Aventis. C. P. A. Fasching received research funding and speaker honoraria from Novartis. E. C.A. Bauer, F. Schochter, P. Widschwendter, A. DeGregorio, T.W.P. Friedl, and C. Scholz have no conflict of interest to declare.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration, its later amendments, and comparable ethical standards.
: Written informed consent was obtained from all study participants prior to study inclusion.
